Article Information
History
- June 21, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rose K Davidson1,*,
- Laura Watts1,
- Gemma Beasy2,
- Shikha Saha2,
- Paul Kroon2,
- Aedin Cassidy3,
- Allan Clark1,
- William Fraser4,
- Iain Mcnamara5,
- Sarah R Kingsbury6,
- Philip G Conaghan6,
- Ian M Clark7 and
- Alex Macgregor1
- 1University of East Anglia, Norwich Medical School, Norwich, United Kingdom
- 2Quadram Institute Bioscience, Food, Microbiome and Health, Norwich, United Kingdom
- 3Queen’s University Belfast, Institute for Global Food Security, Belfast, United Kingdom
- 4Norfolk and Norwich University Hospitals Trust, Depts of Clinical Biochemistry, Endocrinology and Diabetes
- 5Norfolk and Norwich University Hospitals Trust, Institute of Orthopaedics, Norwich, United Kingdom
- 6University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom
- 7University of East Anglia, School of Biological Sciences, Norwich, United Kingdom
- ↵*Corresponding author: Rose K Davidson PhD, r.davidson{at}uea.ac.uk
Posted June 21, 2024.
The BRoccoli In Osteoarthritis (BRIO study) - A randomised controlled feasibility trial to examine the potential protective effect of broccoli bioactives, (specifically sulforaphane), on osteoarthritis
